Clinical Trial: Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition:
Prostate Cancer Surgery
Prostate Cancer Metastatic Disease
Study Type: INTERVENTIONAL
Official Title: Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection (Zopocianine), a Prostate-Specific Membrane Antigen (PSMA)-Targeted Fluorescent Agent, for the Intraope
Brief Summary:
This study is being done to compare how well Zopocianine (OTL78) in combination with Near InfraRed (NIR) fluorescent imaging may improve the detection of malignant (growing in an uncontrolled way) tissue in adult subjects undergoing prostatectomy and lymph node dissection for biopsy confirmed prostate cancer.
Read more